Scleroderma on the face can cause symptoms that may affect your appearance, including the texture, discoloration, and elasticity of your skin. Medications, facial exercises, and dermatological ...

Recently revised consensus diagnostic criteria for tuberous sclerosis complex reflect an improved understanding of its clinical manifestations and its genetic and molecular mechanisms. The ...

Systemic sclerosis (SSc ... main hallmark is tissue and vascular fibrosis that can result in clinical heterogeneity of ...

The Scleroderma Foundation ... Treatments used today only address clinical manifestations, and not the underlying drivers of the disease, and include chemotherapy and stem cell transplantation ...

Professor Christopher Denton discusses key aspects of the 2024 British Society for Rheumatology guideline on managing systemic sclerosis.

Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a ...